To include your compound in the COVID-19 Resource Center, submit it here.

Squeeze on Patent Cooperation Treaty

Applying for patents in the EU via the Patent Cooperation Treaty system soon could become a less desirable option for U.S. companies. Burdened by its extensive backlog of patent applications, the European Patent Office has asked the World International Patent Organization (WIPO) to be relieved of certain examination responsibilities under the treaty, which could affect biotech companies in the U.S., which make extensive use of these services.

There are two ways for an applicant

Read the full 737 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE